Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
2013
1,209 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
44.15
·
European Institute of Oncology
Camelia Chifu
·
European Institute of Oncology
Manuela Sargenti
·
European Institute of Oncology
Mattia Intra
·
European Institute of Oncology
Oreste Gentilini
·
European Institute of Oncology
Mauro G. Mastropasqua
·
European Institute of Oncology
Giovanni Mazzarol
·
European Institute of Oncology
Samuele Massarut
·
Centro di Riferimento Oncologico
Jean‐Remi Garbay
·
Institut Gustave Roussy
Janez Žgajnar
·
Institute of Oncology Ljubljana
Hanne Galatius
·
Herlev Hospital
A. Recalcati
·
Alessandro Manzoni Hospital
David R. G. Littlejohn
·
Calvary Riverina Hospital
Monika Bamert
·
Breast Center
Marco Colleoni
·
European Institute of Oncology
Karen N. Price
·
Dana-Farber Cancer Institute
Meredith M. Regan
·
Harvard University
Aron Goldhirsch
·
European Institute of Oncology
Alan S. Coates
·
University of Sydney
Richard D. Gelber
·
Dana-Farber Cancer Institute
Umberto Veronesi
·
European Institute of Oncology
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial | Researchclopedia